Company: SONM
Filing Date: 2025-09-09
Form Type: PRE 14A
Source: 0001493152-25-012903
Chunk: 17

Company: SONIM TECHNOLOGIES INC
Filing Date: 2025-09-09
Form: PRE 14A
Chunk 17
---
adjustments that may result from the treatment of fractional shares) of the voting power of the outstanding shares of our common stock
immediately after such Reverse Stock Split. The number of stockholders of record will not be affected by a Reverse Stock Split. The Reverse
Stock Split would not change the terms of our common stock.

After the effective time of the Reverse
Stock Split, our common stock will have a new Committee on Uniform Securities Identification Procedures (“CUSIP”) number,
which is a number used to identify our equity securities, and stock certificates with the older CUSIP number (if any) will need to be
exchanged for stock certificates with the new CUSIP number.

Unless the Authorized Shares Proposal is approved by our stockholders and implemented by our board, as more particularly described in “ Proposal 2 — Increase of Authorized Shares of Common Stock,” the number of authorized shares of our common stock will remain at 100,000,000.

The number of authorized shares of
our preferred stock will remain at 5,000,000. The Reverse Stock Split also will not change the number of shares of Series A Junior Participating
Preferred Stock authorized and designated under our Certificate of Incorporation in connection with the adoption of the Company’s
poison pill in the form of a stockholder rights plan.

The Reverse Stock Split is not intended
as, and would not have the effect of, a “going private transaction” covered by Rule 13e-3 under the Exchange Act. Following
the Reverse Stock Split, we would continue to be subject to the periodic reporting requirements of the Exchange Act.

Outstanding warrants

If the Reverse Stock Split is approved
and effected, under the terms of the warrants, the exercise price per share of such warrants will be increased by multiplying the current
exercise price by a fraction of which the numerator shall be the number of shares of our common stock outstanding immediately before
the Reverse Stock Split and of which the denominator shall be the number of shares of our common stock outstanding immediately after
the Reverse Stock Split, and the number of shares issuable upon exercise of the warrants shall be proportionately adjusted such that
the aggregate exercise price of the warrants shall remain unchanged.

Plans and outstanding awards

We maintain our EIP and ESPP (together,
the “Plans”), which are designed primarily to provide stock-based incentives to our employees and other individual service
providers. Our board generally has the discretion to determine the appropriate adjustments to the Plans and outstanding awards and purchase
rights under the Plans in the event